Human Medicines

This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.

HUMAN MEDICINES | RECENTLY PUBLISHED

Summary of CMDh activities 2022
modified 16/03/2023

List of active substances for which data has been submitted in accordance with…
modified 09/03/2023

Added in March 2023 1 March NEW - Report from the meeting held on 21-22…
modified 01/03/2023

Hiberix (Haemophilus influenzae type b vaccine) End of procedure:…
added 01/03/2023

Certican (everolimus) SE/W/0025/pdWS/001 End of procedure:01/06/2017 Date…
modified 01/03/2023

Hydroxychloroquine Date of publication: 01/03/2023
modified 01/03/2023

Position paper on common grounds seen for invalidation/delaying day 0 for…
modified 01/03/2023

Renewals
modified 01/03/2023

CMDh Best Practice Guide on the processing of renewals in the MRP/DCP
modified 01/03/2023

CMDh letter to MAHs of tenofovir disoproxil-containing medicinal…
modified 01/03/2023